Global Platelet, Plasma Market

The Platelet Plasma Market size was valued at USD 485.15 Million in 2023 and the total Platelet Plasma revenue is expected to grow at a CAGR of 12.98% from 2024 to 2030, reaching nearly USD 1139.96 Million.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology :- Request Free Sample Report

A rising incidence of haemophilia, thrombocytopenia, autoimmune diseases as well as other infectious and rare disease will serve to be a key driver for the platelet and plasma market growth. According to the American Academy of Neurology, plasma can be used for the treatment of various neurological conditions. Plasma exchange process involves replacing plasma in a person’s blood. This process can be used for the treatment of conditions such as inflammatory dis-immune neuropathies, multiple sclerosis, myasthenia gravis, and other disorders will accelerate industry growth during the forecast period

Increasing blood transfusion rates in Europe will drive the Platelet, Plasma Market growth over the forecast period. Blood transfusion process is primarily done to isolate the desired blood components such as red blood cells, plasma, platelets and other vital components of the blood. Government initiatives to create awareness regarding source plasma collection, as well as the use of lifesaving plasma protein therapies in rare diseases, will positively impact the market growth.

Advancements in healthcare infrastructure coupled with the increasing number of blood transfusions will directly impact the growth of Platelet, Plasma Market in the coming years. The advent of technologically advanced platelet and plasma products is another major driver that will augment the market growth. Use of platelets and plasma in the treatment of rare, debilitating, life-threatening conditions and chronic diseases such as Hepatitis B heavily influences the growth of the market.

Plasma-derived from blood can be used in treating rare diseases wherein no other alternative treatment is available. For instance, use of plasma for treatment of Ebola virus during its outbreak in West Africa. Factors will augment the market growth during the forecast period.

Platelet segment accounted for the largest market share and will continue to dominate the industry over the forecast period. The reason can be attributed to the increasing adoption of advanced technologies for the treatment of various diseases. Platelets are used in various surgical procedures due to its vivid therapeutic and prophylactic applications. According to the World Federation of Haemophilia (WFH), in , around 2,95,866 people suffered from bleeding disorders wherein 1,84,723 accounted for hemophilia.

The increasing demand of platelets for treatment of hemophilia and other blood disorders will fuel the segment growth over the forecast period. Moreover, various initiatives by the government and other organizations to encourage blood donation among people and the adoption of advanced technologies in developed and developing economies will further boost the industry growth.

North America Platelet, Plasma Market accounted for the highest revenue in and is projected to grow at a significant rate during the forecast period. The growth is attributed to the increasing cases of cancer, obesity, cardiac diseases, neurological disorders, and other chronic diseases. Furthermore, American Red Cross undertakes various initiatives for increasing awareness regarding the importance of blood donation. Blood donation systems in North America are based on a mixed system of non-compensated as well as compensated donations. Moreover, the high demand for advanced technologies coupled with the availability of advanced healthcare infrastructure will augment the regional growth during the forecast period.

Maximize Market Research has comprehensively analyzed Platelet, Plasma Market emphasizing on each segment keeping global and regional dynamics in perspective. The driving forces, as well as considerable restraints, have been explained in depth to attain a balanced scenario. The report classifies Platelet, Plasma Market into various segments such as Component, Distribution Channel, Applications, and Regions providing a thorough understanding of the Platelet and Plasma Ecosystem. Importantly, the report delivers forecasts of the market, giving an insight into the future opportunities that exist in the Platelet, Plasma Market.

The objective of the report is to present comprehensive Platelet, Plasma Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Platelet, Plasma Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Platelet, Plasma Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Platelet, Plasma Market  North America for Asia Pacific make the report investor’s guide.

Platelet Plasma Market Scope: Inquire before buying

Platelet Plasma Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)

Platelet, Plasma Market, Key Players:

1. America’s Blood Centres
2. American Red Cross
3. Blood Centres of America
4. European Blood Alliance
5. Indian Red Cross Society
6. Japanese Red Cross Society
7. Red Cross Society of China
8. Spanish Red Cross
9. Saudi Red Crescent Authority
10. South Africa Red Cross Society.
11. AdiStem Ltd.
12. Arthrex, Inc.
13. Biomet, Inc.
14. Cesca Therapeutics, Inc.
15. DePuy Synthes, Inc.
16. EmCyte Corporation
17. Exactech, Inc.
18. Harvest Technologies Corp.
19. Nuo Therapeutics, Inc.
20. Regen Lab SA
21. Stryker Corporation
22. T-Biotechnology (T-LAB)
23. Arthrex, Inc
24. Terumo BCT, Inc.
25. EmCyte Corporation

Frequently Asked Questions:

1. Which region has the largest share in Global Platelet, Plasma Market?
Ans: North America region holds the highest share in 2023.

2. What is the growth rate of Global Platelet, Plasma Market?
Ans: The Global Platelet, Plasma Market is growing at a CAGR of 12.98% during forecasting period 2024-2030.

3. What is scope of the Global Platelet, Plasma market report?
Ans: Global Platelet, Plasma Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Platelet, Plasma market?
Ans: The important key players in the Global Platelet, Plasma Market are – America’s Blood Centres, American Red Cross, Blood Centres of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China, Spanish Red Cross, Saudi Red Crescent Authority, South Africa Red Cross Society., AdiStem Ltd., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, Stryker Corporation, T-Biotechnology (T-LAB), Arthrex, Inc., Terumo BCT, Inc., and EmCyte Corporation.

5. What was the Global Platelet Plasma Market size in 2023?
Ans: The Global Platelet Plasma Market size was USD 485.15 Million in 2023.